News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
274,026 Results
Type
Article (14291)
Company Profile (105)
Press Release (259622)
Multimedia
Podcasts (65)
Webinars (13)
Section
Business (88331)
Career Advice (465)
Deals (15399)
Drug Delivery (73)
Drug Development (36728)
Employer Resources (50)
FDA (6387)
Job Trends (6237)
News (150795)
Policy (14147)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (444)
Accelerated approval (13)
Adcomms (8)
Allergies (67)
Alliances (23323)
ALS (56)
Alzheimer's disease (481)
Antibody-drug conjugate (ADC) (99)
Approvals (6578)
Artificial intelligence (201)
Autoimmune disease (41)
Automation (12)
Bankruptcy (153)
Best Places to Work (4372)
BIOSECURE Act (9)
Biosimilars (118)
Biotechnology (40)
Bladder cancer (38)
Brain cancer (30)
Breast cancer (172)
Cancer (1318)
Cardiovascular disease (151)
Career advice (418)
Career pathing (13)
CAR-T (50)
CDC (6)
Cell therapy (151)
Cervical cancer (9)
Clinical research (32030)
Collaboration (727)
Compensation (326)
Complete response letters (33)
COVID-19 (779)
CRISPR (43)
C-suite (433)
Cystic fibrosis (58)
Data (1825)
Denatured (18)
Depression (45)
Diabetes (126)
Diagnostics (1383)
Digital health (8)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (113)
Drug pricing (114)
Drug shortages (12)
Duchenne muscular dystrophy (81)
Earnings (33478)
Editorial (20)
Employer branding (4)
Employer resources (45)
Events (39014)
Executive appointments (529)
FDA (7487)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (429)
Gene editing (70)
Generative AI (18)
Gene therapy (166)
GLP-1 (440)
Government (1405)
Grass and pollen (4)
Guidances (164)
Healthcare (3578)
HIV (11)
Huntington's disease (9)
IgA nephropathy (37)
Immunology and inflammation (68)
Immuno-oncology (14)
Indications (53)
Infectious disease (843)
Inflammatory bowel disease (73)
Inflation Reduction Act (7)
Influenza (24)
Intellectual property (113)
Interviews (60)
IPO (5913)
IRA (33)
Job creations (2058)
Job search strategy (374)
JPM (28)
Kidney cancer (9)
Labor market (28)
Layoffs (205)
Leadership (8)
Legal (3458)
Liver cancer (22)
Longevity (8)
Lung cancer (184)
Lymphoma (123)
Machine learning (13)
Management (17)
Manufacturing (412)
MASH (67)
Medical device (1305)
Medtech (1312)
Mergers & acquisitions (9904)
Metabolic disorders (436)
Multiple sclerosis (48)
NASH (14)
Neurodegenerative disease (84)
Neuropsychiatric disorders (37)
Neuroscience (893)
Neurotech (1)
NextGen: Class of 2026 (1588)
Non-profit (604)
Now hiring (17)
Obesity (229)
Opinion (141)
Ovarian cancer (39)
Pain (110)
Pancreatic cancer (51)
Parkinson's disease (80)
Partnered (11)
Patents (221)
Patient recruitment (116)
Peanut (12)
People (29784)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase 1 (8307)
Phase 2 (13524)
Phase 3 (12215)
Pipeline (1915)
Policy (135)
Postmarket research (1401)
Preclinical (3340)
Press Release (25)
Prostate cancer (84)
Psychedelics (16)
Radiopharmaceuticals (135)
Rare diseases (353)
Real estate (2659)
Recruiting (18)
Regulatory (10967)
Reports (15)
Research institute (574)
Resumes & cover letters (55)
Rett syndrome (5)
RNA editing (6)
RSV (20)
Schizophrenia (69)
Series A (80)
Series B (49)
Service/supplier (2)
Sickle cell disease (46)
Special edition (10)
Spinal muscular atrophy (81)
Sponsored (9)
Startups (1645)
State (2)
Stomach cancer (5)
Supply chain (49)
Tariffs (68)
The Weekly (45)
Vaccines (231)
Venture capital (32)
Weight loss (141)
Women's health (27)
Worklife (4)
Date
Today (21)
Last 7 days (152)
Last 30 days (678)
Last 365 days (10435)
2026 (974)
2025 (10721)
2024 (12503)
2023 (14252)
2022 (19577)
2021 (20084)
2020 (19054)
2019 (14902)
2018 (11721)
2017 (13901)
2016 (13136)
2015 (15487)
2014 (12425)
2013 (10608)
2012 (11396)
2011 (11923)
2010 (10894)
Location
Africa (318)
Alabama (19)
Alaska (1)
Arizona (77)
Arkansas (3)
Asia (20896)
Australia (2689)
California (3183)
Canada (1486)
China (552)
Colorado (143)
Connecticut (129)
Delaware (123)
Europe (40898)
Florida (601)
Georgia (63)
Hawaii (1)
Idaho (10)
Illinois (349)
India (44)
Indiana (241)
Iowa (2)
Japan (247)
Kansas (77)
Kentucky (20)
Louisiana (4)
Maine (2)
Maryland (422)
Massachusetts (2590)
Michigan (46)
Minnesota (165)
Mississippi (1)
Missouri (33)
Montana (8)
Nebraska (7)
Nevada (16)
New Hampshire (8)
New Jersey (1398)
New Mexico (7)
New York (906)
North Carolina (619)
North Dakota (2)
Northern California (1449)
Ohio (80)
Oklahoma (5)
Oregon (18)
Pennsylvania (720)
Puerto Rico (12)
Rhode Island (17)
South America (508)
South Carolina (10)
Southern California (1391)
Tennessee (53)
Texas (455)
United States (12689)
Utah (59)
Virginia (160)
Washington D.C. (42)
Washington State (223)
West Virginia (1)
Wisconsin (37)
Wyoming (1)
274,026 Results for "mallinckrodt pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Par Health Completes Spin-Off from Mallinckrodt, Creating an Independent Leader in Generic Pharmaceuticals and Sterile Injectables
November 10, 2025
·
7 min read
Press Releases
Mallinckrodt Reports Third Quarter 2025 Financial Results
November 10, 2025
·
26 min read
Press Releases
Mallinckrodt Completes Spin-Off of Par Health, Introduces Keenova Therapeutics
November 10, 2025
·
11 min read
Press Releases
Mallinckrodt to Present Data on Terlipressin at the 2025 American Association for the Study of Liver Diseases (AASLD) Annual Meeting
October 31, 2025
·
7 min read
Mergers & acquisitions
Troubled Drugmakers Mallinckrodt, Endo Officially Announce $6.7B Merger
Both Mallinckrodt and Endo have previously declared bankruptcy, linked to opioid-related lawsuits.
March 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Mallinckrodt plc to Report Third Quarter 2025 Financial Results on November 10, 2025
October 24, 2025
·
2 min read
Press Releases
Mallinckrodt to Present Data on Terlipressin in Patients with Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI) at Kidney Week 2025
October 31, 2025
·
9 min read
Press Releases
Mallinckrodt Names Dr. Marek J. Honczarenko as EVP and Chief Scientific Officer
September 23, 2025
·
4 min read
Press Releases
Mallinckrodt Names Leslie Donato to Board of Directors
August 5, 2025
·
3 min read
Press Releases
Mallinckrodt plc to Report Earnings Results for Second Quarter 2025
July 23, 2025
·
2 min read
1 of 27,403
Next
